VasoDynamics is a UK-based pharmaceutical development company with a pipeline of drugs in development to address the side-effects associated with cancer therapies.  We are a young company with experienced and diversified executives and a shared vision to improve the standard of cancer care globally.  With mounting cost pressures facing healthcare payers all over the world, we are developing cost-efficient medicines which aim to prevent the debilitating, and often dose-limiting, complications of cancer therapy such as skin/mucosa damage and hair-loss.  We take great pride in our culture of scientific and development rigour, and our programmes are based on robust science from world-leading research bodies.

Learn more about Catalyser

Spaces are limited to maximum 10 companies per cohort, learn more about our next programme by writing to

Learn More

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.